US states file second lawsuit accusing Aurobindo Pharma, others firms for violating antitrust laws
Updated : May 14, 2019 11:21 AM IST
Aurobindo Pharma said it is currently reviewing the second lawsuit and said "we expect that we will be filing papers with the Federal Court in due course denying each of the relevant accusations".
Earlier in December 2016, the first lawsuit (First State AG Action) was filed in Federal Court alleging that Aurobindo and other companies in the US generic drug industry had violated antitrust laws by fixing prices and allocating customers.
Have you signed up for Primo, our daily newsletter?It has all the stories and data on the market, business, economy and tech that you need to know.
THANK YOU! You made our day. See you every morningYOUR EMAIL IS ON ITS WAY. Check your inbox for future updates.
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more